CMS yesterday updated its FAQ for state Medicaid and Children’s Health Insurance Program agencies, answering questions related to flexibilities related to managed care, benefits, financing, Section 1115 demonstrations, and Section 1135 waivers offered as part of the president’s declaration of a national emergency. 

The agency also clarified coverage of COVID-19 diagnosis and treatment by catastrophic health plans. The document aligns with guidance released last week by the Internal Revenue Service, which gave high deductible health plans flexibility to provide COVID-19 diagnosis and treatment benefits without deductibles or cost-sharing.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services Feb. 20 finalized proposed changes to how states calculate the hospital-specific cap for Medicaid…
Perspective
Two presidents that America honors with a federal holiday on Monday shared a number of memorable traits. George Washington and Abraham Lincoln were blessed…
Headline
The AHA, joined by five other national associations representing hospitals, Feb. 2 urged the U.S. Supreme Court to review a case challenging how the Department…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
The Medicaid and CHIP Payment and Access Commission (MACPAC) last week recommended seven changes to Medicaid managed care policy to better monitor denials and…
Headline
In an interview Jan. 17 in the Washington Post’s Health 202 newsletter, AHA President and CEO Rick Pollack explains why ‘site-neutral’ Medicare proposals…